Search Results - "Meltzer, Eli O"

The economic impact of allergic rhinitis and current guidelines for treatment by Meltzer, Eli O., MD, Bukstein, Don A., MD

“…Objective To describe the economic burden of allergic rhinitis treatment and current guidelines for treatment. Data Sources Review articles and original…”
Get full text

Burden of allergic rhinitis: Results from the Pediatric Allergies in America survey by Meltzer, Eli O., MD, Blaiss, Michael S., MD, Derebery, M. Jennifer, MD, Mahr, Todd A., MD, Gordon, Bruce R., MD, Sheth, Ketan K., MD, Simmons, A. Larry, MD, Wingertzahn, Mark A., PhD, Boyle, John M., PhD

“…Allergic rhinitis (AR), a chronic inflammatory disease of the upper airway, is one of the most common chronic diseases in the United States and is estimated to…”
Get full text

Findings from an Online Survey Assessing the Burden and Management of Seasonal Allergic Rhinoconjunctivitis in US Patients by Meltzer, Eli O., MD, Farrar, Judith Rosen, PhD, Sennett, Cary, MD, PhD

“…Background Seasonal allergic rhinoconjunctivitis (SARC) affects ≥16% of the US population annually. Telephone and in-office surveys have demonstrated negative…”
Get full text

Treatment effect of sublingual immunotherapy tablets and pharmacotherapies for seasonal and perennial allergic rhinitis: Pooled analyses by Durham, Stephen R., MD, Creticos, Peter S., MD, Nelson, Harold S., MD, Li, Ziliang, PhD, Kaur, Amarjot, PhD, Meltzer, Eli O., MD, Nolte, Hendrik, MD, PhD

“…Background Data comparing the treatment effect of allergy immunotherapy and pharmacotherapy are lacking. Objective We sought to indirectly compare the…”
Get full text

Fexofenadine: review of safety, efficacy and unmet needs in children with allergic rhinitis by Meltzer, Eli O, Rosario, Nelson Augusto, Van Bever, Hugo, Lucio, Luiz

“…Allergic rhinitis (AR) is the most common undiagnosed chronic condition in children. Moderate/severe AR symptoms significantly impair quality of life, and…”
Get full text

Tiotropium or salmeterol as add-on therapy to inhaled corticosteroids for patients with moderate symptomatic asthma: two replicate, double-blind, placebo-controlled, parallel-group, active-comparator, randomised trials by Kerstjens, Huib A M, Prof, Casale, Thomas B, Prof, Bleecker, Eugene R, Prof, Meltzer, Eli O, MD, Pizzichini, Emilio, Prof, Schmidt, Olaf, MD, Engel, Michael, MD, Bour, Loek, MSc, Verkleij, Cynthia B, BSc, Moroni-Zentgraf, Petra, MD, Bateman, Eric D, Prof

“…Summary Background In patients with severe asthma, tiotropium improves lung function and exacerbation risk when added to high-dose inhaled corticosteroids plus…”
Get full text

Reliability, validity, and responsiveness of the Rhinitis Control Assessment Test in patients with rhinitis by Meltzer, Eli O., MD, Schatz, Michael, MD, Nathan, Robert, MD, Garris, Cindy, MS, Stanford, Richard H., PharmD, MS, Kosinski, Mark, MS

“…Background The Rhinitis Control Assessment Test (RCAT) is a brief, patient-completed tool to evaluate rhinitis symptom control. Objective We sought to test the…”
Get full text

Pharmacotherapeutic strategies for allergic rhinitis: matching treatment to symptoms, disease progression, and associated conditions by Meltzer, Eli O

“…The selection of specific pharmacotherapy for patients with allergic rhinitis (AR) depends on several factors, including age, most prominent symptoms, symptom…”
Get more information

Safety and efficacy of the prostaglandin D2 receptor antagonist AMG 853 in asthmatic patients by Busse, William W., MD, Wenzel, Sally E., MD, Meltzer, Eli O., MD, Kerwin, Edward M., MD, Liu, Mark C., MD, Zhang, Nan, PhD, Chon, Yun, PhD, Budelsky, Alison L., PhD, Lin, Joseph, MD, Lin, Shao-Lee, MD, PhD

“…Background The D-prostanoid receptor and the chemoattractant receptor homologous molecule expressed on TH 2 cells (CRTH2) are implicated in asthma…”
Get full text

Burden of allergic rhinitis: allergies in America, Latin America, and Asia-Pacific adult surveys by Meltzer, Eli O, Blaiss, Michael S, Naclerio, Robert M, Stoloff, Stuart W, Derebery, M Jennifer, Nelson, Harold S, Boyle, John M, Wingertzahn, Mark A

“…Allergic rhinitis (AR; also nasal allergies or "hay fever") is a chronic upper airway inflammatory disease that affects ∼60 million adults and children in the…”
Get more information

Allergic Rhinitis: Burden of Illness, Quality of Life, Comorbidities, and Control by Meltzer, Eli O

“…Allergic rhinitis is a highly prevalent and costly condition. The disease burden suffered by patients includes the morbidity of the nasal symptoms, the…”
Get full text

Minimal Clinically Important Difference (MCID) in Allergic Rhinitis: Agency for Healthcare Research and Quality or Anchor-Based Thresholds? by Meltzer, Eli O., MD, Wallace, Dana, MD, Dykewicz, Mark, MD, Shneyer, Lucy, MA

“…Background In 2013, the Agency for Healthcare Research and Quality (AHRQ) recommended that allergic rhinitis (AR) studies calculate a minimal clinically…”
Get full text

Intranasal spray medications for maintenance therapy of allergic rhinitis by Berger, William E, Meltzer, Eli O

“…Intranasal sprays are recommended as targeted therapy for allergic rhinitis (AR) by providing direct delivery of medication to the nasal mucosa, reducing the…”
Get full text

Correction: Fexofenadine: review of safety, efficacy and unmet needs in children with allergic rhinitis by Meltzer, Eli O, Rosario, Nelson Augusto, Van Bever, Hugo, Lucio, Luiz

Get full text

Use of the Asthma Control Questionnaire to predict future risk of asthma exacerbation by Meltzer, Eli O., MD, Busse, William W., MD, Wenzel, Sally E., MD, Belozeroff, Vasily, PhD, Weng, Haoling H., MD, MHS, Feng, JingYuan, MS, Chon, Yun, PhD, Chiou, Chiun-Fang, PhD, Globe, Denise, PhD, Lin, Shao-Lee, MD, PhD

“…Background Direct correlation of assessments of a validated composite measure such as the Asthma Control Questionnaire (ACQ) and risk of exacerbation has not…”
Get full text

Peak expiratory flow as an endpoint for clinical trials in asthma: a comparison with FEV1 by Halpin, David M. G, Meltzer, Eli O, Pisternick-Ruf, Wendelgard, Moroni-Zentgraf, Petra, Engel, Michael, Zaremba-Pechmann, Liliana, Casale, Thomas, FitzGerald, J. Mark

“…Background The primary lung function endpoint in clinical trials in adolescent and adult patients with asthma is usually forced expiratory volume in one second…”
Get full text

Rhinosinusitis Diagnosis and Management for the Clinician: A Synopsis of Recent Consensus Guidelines by Meltzer, Eli O., MD, Hamilos, Daniel L., MD

“…Rhinosinusitis (RS) affects approximately 1 in 7 adults in the United States, and its effect on quality of life, productivity, and finances is substantial…”
Get full text

ICON: chronic rhinosinusitis by Bachert, Claus, Pawankar, Ruby, Zhang, Luo, Bunnag, Chaweewan, Fokkens, Wytske J, Hamilos, Daniel L, Jirapongsananuruk, Orathai, Kern, Robert, Meltzer, Eli O, Mullol, Joaquim, Naclerio, Robert, Pilan, Renata, Rhee, Chae-Seo, Suzaki, Harumi, Voegels, Richard, Blaiss, Michael

“…Chronic rhinosinusitis (CRS) is a public health problem that has a significant socio-economic impact. Moreover, the complexity of this disease due to its…”
Get full text

An algorithm for the management of allergic conjunctivitis by Bielory, Leonard, Meltzer, Eli O, Nichols, Kelly K, Melton, Ron, Thomas, Randall K, Bartlett, Jimmy D

“…Allergic conjunctivitis has been reported to be increasing in prevalence in the United States. It significantly impacts patient quality of life and reduces…”
Get more information

Sleep, quality of life, and productivity impact of nasal symptoms in the United States: findings from the Burden of Rhinitis in America survey by Meltzer, Eli O, Nathan, Robert, Derebery, Jennifer, Stang, Paul E, Campbell, Ulka B, Yeh, Wei-Shi, Corrao, Marlo, Stanford, Richard

“…Rhinitis is a common chronic condition that has been shown in observational and interventional studies to have a substantial impact on the sufferer. This study…”
Get more information